Maaike de Fost

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

Rolf G. Boot, Marri Verhoek, Maaike de Fost et al. · Blood · 2003 · 338 citations · Full text

Life Sciences, Immunology, Pathology +15

Increased incidence of cancer in adult Gaucher disease in Western Europe

Maaike de Fost, Stephan vom Dahl, Gerrit Jan Weverling et al. · Blood Cells Molecules and Diseases · 2005 · 181 citations

Medicine, Health Sciences, Oncology +11

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis

Maaike de Fost, Carla E. M. Hollak, J.E.M. Groener et al. · Blood · 2006 · 143 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +9

Increased plasma macrophage inflammatory protein (MIP)-1α and MIP-1β levels in type 1 Gaucher disease

Mariëlle J. van Breemen, Maaike de Fost, Jane S.A. Voerman et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2007 · 113 citations · Full text

Life Sciences, Immunology, Pathobiology +15

Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease

Holger Jon Møller, Maaike de Fost, Carla E. M. Hollak et al. · European Journal Of Haematology · 2004 · 107 citations

Life Sciences, Hematology, Immunology +14